electroCore, Inc.
$6.31
▲
3.03%
2026-04-21 06:33:01
www.electrocore.com
NCM: ECOR
Explore electroCore, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$51.01 M
Current Price
$6.31
52W High / Low
$8.64 / $4.16
Stock P/E
—
Book Value
$-0.21
Dividend Yield
—
ROCE
-179.71%
ROE
-4.79%
Face Value
—
EPS
$-1.65
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
83
Beta
0.6
Debt / Equity
-5.5
Current Ratio
1.38
Quick Ratio
1.24
Forward P/E
-11.05
Price / Sales
1.53
Enterprise Value
$46.94 M
EV / EBITDA
-3.71
EV / Revenue
1.47
Rating
None
Target Price
$19.8
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | UFP Technologies, Inc. | $201.08 | 22.53 | $1.54 B | — | 16.02% | 17.82% | $274.93 / $182.87 | $54.95 |
| 2. | SS Innovations International, Inc. | $4.85 | — | $971.12 M | — | -17.08% | -46.94% | $22.42 / $3.02 | $0.2 |
| 3. | Integer Holdings Corporation | $89.32 | 29.89 | $3.07 B | — | 7.52% | 6.11% | $127.56 / $62 | $50.85 |
| 4. | SANUWAVE Health, Inc. | $19.94 | 14.99 | $177.13 M | — | 25.36% | -166.66% | $46.59 / $16.27 | $0.19 |
| 5. | iTonic Holdings Ltd. | $0.32 | — | $5.41 M | — | -59.82% | -71.25% | $32 / $0.25 | $0.36 |
| 6. | Neogen Corporation | $9.63 | — | $2.08 B | — | -0.05% | -25.57% | $11.43 / $4.32 | $9.68 |
| 7. | CeriBell, Inc. | $21.13 | — | $797.62 M | — | -33.07% | -30.83% | $24.33 / $10.85 | $4.14 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 9.24 M | 8.69 M | 7.38 M | 6.72 M | 7.05 M | — |
| Operating Profit | -2.94 M | -2.88 M | -3.51 M | -3.82 M | -3.07 M | — |
| Net Profit | -3.04 M | -3.4 M | -3.67 M | -3.85 M | -3.23 M | — |
| EPS in Rs | -0.38 | -0.42 | -0.45 | -0.48 | -0.4 | -0.31 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 32.03 M | 25.18 M | 16.03 M | 8.59 M |
| Operating Profit | -13.15 M | -12.16 M | -19.27 M | -22.87 M |
| Net Profit | -13.97 M | -11.89 M | -18.83 M | -22.16 M |
| EPS in Rs | -1.73 | -1.47 | -2.33 | -2.74 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 18.67 M | 20.47 M | 16.1 M | 24.76 M |
| Total Liabilities | 20.38 M | 12.93 M | 8.66 M | 7.67 M |
| Equity | -1.71 M | 7.54 M | 7.44 M | 17.09 M |
| Current Assets | 15.67 M | 16.3 M | 14.29 M | 21.17 M |
| Current Liabilities | 11.35 M | 9.15 M | 8.12 M | 7.04 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -8.19 M | -6.95 M | -14.67 M | -16.64 M |
| Investing CF | 3.88 M | -8.52 M | -0.21 M | 0 M |
| Financing CF | 7.63 M | 8.44 M | 7.49 M | 0 M |
| Free CF | -8.25 M | -6.95 M | -14.87 M | -16.64 M |
| Capex | -0.07 M | — | -0.21 M | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 57.09% | 86.57% | — | — |
| Earnings Growth % | 36.89% | 15.02% | — | — |
| Profit Margin % | -47.2% | -117.49% | -257.94% | — |
| Operating Margin % | -48.3% | -120.21% | -266.22% | — |
| Gross Margin % | 84.97% | 82.51% | 81.19% | — |
| EBITDA Margin % | -41.03% | -113.81% | -259.29% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2023-02-15 | 1:0.0666667 |